#InfluencerEthics

A social media fitness influencer with over five million followers has ignited a widespread controversy after publicly sharing that her recent weight loss success involved the use of a GLP-1 class medication, commonly known by names such as Ozempic and Mounjaro. The disclosure, made in a YouTube video titled “Let’s talk: Therapy, GLP-1 & The Truth About My Recent Weight Loss,” has set off heated discussions about transparency, ethical responsibility, and the realities of the online wellness industry.